Brief: Harpoon Therapeutics Announces First Patients With Small Cell Lung Cancer Dosed In Hpn328 Combination Cohort
15/09/2023 12:32
Harpoon Therapeutics Inc HARP.O :
* HARPOON THERAPEUTICS ANNOUNCES FIRST PATIENTS WITH SMALL
CELL
LUNG CANCER DOSED IN HPN328 COMBINATION COHORT
Source text for Eikon: ID:nGNX6Jhg4b
Further company coverage: HARP.O
Recent news on Harpoon Therapeutics
See all newsBrief: Harpoon Therapeutics Receives 17 Additional Demands Seeking Disclosures in Proxy Statement
U.S. RESEARCH ROUNDUP-Axonics, BlackRock, Credit Acceptance
U.S. STOCKS ON THE MOVE-Core & Main, Commercial Metals, Equifax
U.S. STOCKS ON THE MOVE-Toll Brothers, American Eagle Outfitters, Twilio
Wrapup 1: Drugmakers kick off industry conference with two cancer deals